NASDAQ · Healthcare · Medical - Instruments & Supplies
Pulse Biosciences, Inc.
PLSE
Pulse Biosciences, Inc. CEO Paul Arthur LaViolette · Market cap $1.6B.
$23.30
+4.22 · +22.12%
52w hi $26.3052w lo $12.56
Off 52w high 27.4%
84
STRONG
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
2 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $30.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 11 | Robert W Duggan | Buy | 660,233 | $19.69 | +$13.00M | 75 | |
| May 11 | Paul A Laviolette | Chief Executive Officer | Buy | 15,000 | $19.69 | +$295K | 84 |
| Sep 10 | Robert W Duggan | Buy | 34,659 | $14.66 | +$508K | 43 | |
| Sep 12 | Robert W Duggan | Buy | 145,140 | $14.41 | +$2.09M | 46 | |
| Sep 11 | Robert W Duggan | Buy | 12,800 | $14.77 | +$189K | 40 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay